AI assistant
Ajanta Pharma Ltd. — Call Transcript 2022
Oct 27, 2022
59171_rns_2022-10-27_fa462621-b867-4033-accb-86e3b29ecc75.pdf
Call Transcript
Open in viewerOpens in your device viewer
Ajanta House T +91 22 6606 1000 Charkop, Kandivli West, F +91 22 6606 1200 Mumbai 400 067 E [email protected] India W www.ajantapharma.com
==> picture [292 x 27] intentionally omitted <==
27[th] October 2022
BSE Limited National Stock Exchange of India, Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot No. C/1, Dalal Street, G block, Bandra Kurla Complex, Mumbai - 400 001 Bandra (East), Mumbai - 400 051 Scrip Code: BSE – AJANTPHARM 532331 Scrip Code: NSE AJANTPHARM EQ
Sub: Earnings Conference Call
Dear Sir / Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith the schedule of Earnings Conference Call to be held on 3[rd] November 2022, post Board meeting.
This is for your information and records please.
Yours Faithfully,
GAURAN Digitally signed G by GAURANG CHINUBHAI CHINUBH SHAH Date: 2022.10.27 AI SHAH 16:52:23 +05'30'
Gaurang Shah
VP – Legal & Company Secretary
Encl.: a/a
Page 1 of 2
Corporate Identity Number – L24230MH1979PLC022059
Ajanta House T +91 22 6606 1000 Charkop, Kandivli West, F +91 22 6606 1200 Mumbai 400 067 E [email protected] India W www.ajantapharma.com
==> picture [292 x 27] intentionally omitted <==
Announcement
Ajanta Pharma to release Q2 FY 2023 Unaudited Financial Results on 3[rd] November 2022
1700 hrs. – EARNINGS CONFERENCE CALL
The Company will host an Earnings Conference Call at 1700 hrs. IST (1930 hrs. SST/HKT, 1230 hrs. BST, 0730 hrs. US ET), during which the leadership team will discuss the financial performance and take questions. A transcript of the conference call will be available at www.ajantapharma.com.
Earnings Conference Call Dial-in Information
| Date and Time | 3rd November 2022at 1700 – 1800 hrs IST 1930 – 2030 hrs SST/HKT 1230 – 1330 hrs BST 0730 – 0830 hrs US ET |
|---|---|
| Dial-in Numbers | |
| Universal Access | Primary Access:(+91 22 6280 1542) (+91 22 7115 8372) |
| Diamondpass link | Click hereto register |
| International Toll | USA:+1 3233868721 UK:+44 2034785524 Hong Kong:+852 30186877 Singapore:+65 31575746 |
| International Toll Free | USA:18667462133 UK:08081011573 Hong Kong:800964448 Singapore:8001012045 |
Playback of Earnings Conference Call audio:
Playback of the earnings call will be available 120 minutes after the end of the call on our website (www.ajantapharma.com).
Contact:
Investor Relations
Rajeev Agarwal Abhineet Kumar E-Mail: [email protected] E-Mail: [email protected]
Page 2 of 2
Corporate Identity Number – L24230MH1979PLC022059